Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Curasight – Præsentation af helårsrapport 2023 og ny terapeutisk strategi

By HC Andersen Capital
Curasight

Mød og stil spørgsmål til Curasights CEO Ulrich Krasilnikoff og CSO Andreas Kjær, der vil gennemgå årsregnskabet for 2023 d. 27. februar kl. 10:30.

Herudover har Curasight efter årsafslutningen 2023 annonceret en kapitalforhøjelse med fortegningsret for eksisterende aktionærer som skal finansiere selskabets nye terapeutiske strategi. Fortegningsemissionen løber fra den 23. februar til den 7. marts.

Disclaimer: HC Andersen Capital modtager betaling fra Curasight for en DigitalIR/Corporate Visibility aftale./Claus Thestrup 13-02-2024 kl. 15.35.

Recent videos

Orion as an Investment | Life Science Night Dec. 9, 2025
13.12.2025 klo 13.50 Orion
A sit-down with CEO Remco Westermann
12.12.2025 klo 10.09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
11.12.2025 klo 12.00 Aiforia Technologies
Endomines as an Investment | Investor Day Nov. 24, 2025
10.12.2025 klo 13.30 Endomines Finland
Clas Ohlson, Audiocast, Q2'25
10.12.2025 klo 10.00 Clas Ohlson
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.